Učitavanje...
Systematic review and network meta-analysis of approved medicines for the treatment of idiopathic pulmonary fibrosis
Background: Clinical practice guidelines for the treatment of idiopathic pulmonary fibrosis (IPF) currently recommend pirfenidone and nintedanib. However, there is a lack of evidence from head-to-head comparisons. Objectives: To perform a systematic review and network meta-analysis (NMA) to access t...
Spremljeno u:
| Izdano u: | J Drug Assess |
|---|---|
| Glavni autori: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Taylor & Francis
2019
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6484486/ https://ncbi.nlm.nih.gov/pubmed/31044096 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21556660.2019.1597726 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|